Vertex Pharma (VRTX) Tops Q1 EPS by 13c
Tweet
Share
E-mailGet Alerts VRTX Hot Sheet
Price: $505.75 --0%
Financial Fact:
Loss from operations: -18.73M
Today's EPS Names:
AFIB, USDP, BTTX, More
Financial Fact:
Loss from operations: -18.73M
Today's EPS Names:
AFIB, USDP, BTTX, More
Join SI Premium – FREE
Vertex Pharma (NASDAQ: VRTX) reported Q1 EPS of ($0.62), $0.13 better than the analyst estimate of ($0.75). Revenue for the quarter came in at $138.5 million versus the consensus estimate of $142.38 million.
For earnings history and earnings-related data on Vertex Pharma (VRTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Investcorp Credit Management BDC, Inc. (ICMB) Misses Q2 EPS by 12c
- Allogene (ALLO) Reiterated at Market Outperform by Citizens: 'ALPHA3 Trial is On-Track'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
